SULFASALAZINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for sulfasalazine and what is the scope of patent protection?
Sulfasalazine
is the generic ingredient in four branded drugs marketed by Pharmacia And Upjohn, Pfizer, Nuvo Pharms Inc, Watson Labs, Solvay, Chartwell, Epic Pharma Llc, Sun Pharm Industries, and Superpharm, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for sulfasalazine. Nine suppliers are listed for this compound.
Summary for SULFASALAZINE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 9 |
NDAs: | 13 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 142 |
Clinical Trials: | 100 |
Patent Applications: | 6,953 |
Drug Prices: | Drug price trends for SULFASALAZINE |
What excipients (inactive ingredients) are in SULFASALAZINE? | SULFASALAZINE excipients list |
DailyMed Link: | SULFASALAZINE at DailyMed |
Recent Clinical Trials for SULFASALAZINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tanta University | Phase 3 |
Cairo University | Phase 3 |
Rutgers, The State University of New Jersey | Phase 2 |
Pharmacology for SULFASALAZINE
Drug Class | Aminosalicylate |
Medical Subject Heading (MeSH) Categories for SULFASALAZINE
Anatomical Therapeutic Chemical (ATC) Classes for SULFASALAZINE
US Patents and Regulatory Information for SULFASALAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Industries | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 089590-001 | Oct 19, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nuvo Pharms Inc | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 040349-001 | Jan 11, 2002 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Solvay | S.A.S.-500 | sulfasalazine | TABLET;ORAL | 083450-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 086184-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | AZULFIDINE EN-TABS | sulfasalazine | TABLET, DELAYED RELEASE;ORAL | 007073-002 | Apr 6, 1983 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.